As the legalization of cannabidiol (CBD) and cannabis-derived products for medical applications grows further in the European Union, so do the studies around the subject.
Researchers and corporations worldwide are interested in assessing the impact that CBD and other cannabis products may have on the market, if they have medicinal value, and what disorders they can treat, or in what treatments they may work as complementary medicines. So far, CBD oil studies have demonstrated very promising results regarding the treatment or management of many different conditions.
Recently, the English Eos Scientific company, which specializes in testing and analyzing products, conducted a study regarding the medical preferences of the adult UK population.
The fact that the current prescription medicines indicated to treat or manage mental issues very often have severe side effects and may cause extreme addiction, instills fear and apprehension among the population. Therefore, many adults are starting to avoid taking this type of medications or even seeing a doctor for their mental health issues.
As a result, the appearance of CBD products like CBD oil came as an option for many people who prefer not to take the conventional approach for managing mental issues.
In fact, the study conducted by Eos Scientific revealed that around 30% of the British adult population (around 15 million adults, 47% of them aged between 18-34) is concerned about seeing a doctor regarding their mental health, as they fear being prescribed medication that is too strong for their symptoms and then suffer the side effects.
On the other hand, the study also found that while 11.3 million UK residents (around 24% of UK adults, 35% of them aged between 18-34) choose to manage their mental health using holistic medicines and remedies, 17.5 million prefer to use CBD oil.
This means that around 38% of UK adults, half of them aged between 18-34 (the so-called Millennials), are more inclined to use CBD products to manage mental issues than they are to see a conventional doctor or take conventional prescribed medication.
Regarding these results, Simon Manthorpe, CEO of the company that conducted the study, refers that “the number of UK users of CBD oil has almost doubled in the last year, with many claiming the cannabis-based products are a more natural and easily accessible way to manage their mental health”.
In fact, the CEO also points out that “while prescribed medicine will always be the recommendation of medical professionals, we are seeing increasing numbers of people turning to more alternative remedies, not just for their mental health but for any number of ailments”.
This tendency raises important questions regarding the future of medicine. The benefits cannabis- derived products showed in managing mental issues such as anxiety, schizophrenia, psychosis, or bipolar disorder shows we may be facing a new dawn regarding the use of more natural medicines and approaches to manage mental issues that, so far, were thought to only be possibly solved or controlled using strong prescription drugs, which are also sometimes dangerous or even ineffective.